ATE468121T1 - Zusammensetzungen zur verringerung des blutglukosespiegels und zur behandlung von diabetes - Google Patents

Zusammensetzungen zur verringerung des blutglukosespiegels und zur behandlung von diabetes

Info

Publication number
ATE468121T1
ATE468121T1 AT07751372T AT07751372T ATE468121T1 AT E468121 T1 ATE468121 T1 AT E468121T1 AT 07751372 T AT07751372 T AT 07751372T AT 07751372 T AT07751372 T AT 07751372T AT E468121 T1 ATE468121 T1 AT E468121T1
Authority
AT
Austria
Prior art keywords
compositions
alpha
glucose levels
crpic
kgm
Prior art date
Application number
AT07751372T
Other languages
English (en)
Inventor
Eric Hayes
Alexander Zolotoy
Original Assignee
Astrum Therapeutics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrum Therapeutics Pty Ltd filed Critical Astrum Therapeutics Pty Ltd
Application granted granted Critical
Publication of ATE468121T1 publication Critical patent/ATE468121T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/06—Phenols the aromatic ring being substituted by nitro groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07751372T 2006-02-21 2007-02-21 Zusammensetzungen zur verringerung des blutglukosespiegels und zur behandlung von diabetes ATE468121T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77518806P 2006-02-21 2006-02-21
PCT/US2007/004604 WO2007098240A2 (en) 2006-02-21 2007-02-21 Compositions to reduce blood glucose levels and treat diabetes

Publications (1)

Publication Number Publication Date
ATE468121T1 true ATE468121T1 (de) 2010-06-15

Family

ID=38308656

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07751372T ATE468121T1 (de) 2006-02-21 2007-02-21 Zusammensetzungen zur verringerung des blutglukosespiegels und zur behandlung von diabetes

Country Status (8)

Country Link
US (2) US20070254047A1 (de)
EP (1) EP1996176B1 (de)
CN (1) CN101437503A (de)
AT (1) ATE468121T1 (de)
AU (1) AU2007217500A1 (de)
CA (1) CA2643299A1 (de)
DE (1) DE602007006641D1 (de)
WO (1) WO2007098240A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652550B2 (en) 2008-01-16 2014-02-18 Hydro One, Llc Health beverages comprising cinnamon extract and methods of making and using the same
US20100099751A1 (en) * 2008-10-21 2010-04-22 Al-Mulla Fahd Method of treating diabetes-related vascular complications
CA2642184A1 (en) 2008-10-28 2010-04-28 Goliath Oil And Gas Corporation Composition containing ginseng and cinnamon
US20100178413A1 (en) * 2008-12-17 2010-07-15 Mark Gorris Food-based Supplement Delivery System
US9918489B2 (en) 2008-12-17 2018-03-20 Mark Gorris Food-based supplement delivery system
CN101947238B (zh) * 2010-06-24 2011-12-21 攀枝花兴辰钒钛有限公司 治疗癌症的药物组合物及其用途
ES2395529B1 (es) 2011-06-08 2014-04-11 Pri, S.A. Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2.
CN102526198A (zh) * 2012-03-14 2012-07-04 南昌大学 一种以肉桂和铬为添加剂的药品及保健品的制备方法
US20130330422A1 (en) * 2012-06-07 2013-12-12 The Board Of Trustees Of The University Of Alabama Methods for increasing insulin sensitivity and treating diabetes with a bioactive chromium binding peptide
CN103436582B (zh) * 2013-07-10 2015-12-23 马杰坤 一种魔芋多肽提取物、制备方法及其用途
AU2019239797B2 (en) * 2018-03-20 2024-04-04 Exerkine Corporation Weight management composition
CN110634567A (zh) * 2018-06-21 2019-12-31 北京东方兴企食品工业技术有限公司 用于评估糖代谢及糖尿病并发症风险的系统
CN109745359A (zh) * 2019-03-08 2019-05-14 储殷 有利于保持血糖平衡和预防糖尿病及其并发症的组合物及其制备方法
CN112890177A (zh) * 2021-02-24 2021-06-04 云南屯屯麦生物技术研究有限公司 一种用于降低妊娠期餐后血糖水平的组合物及其制备方法
CN117481300A (zh) * 2023-11-09 2024-02-02 南京财经大学 一种营养重组米及其制备方法和在稳定t2dm餐后血糖中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
JPH08127538A (ja) * 1994-10-31 1996-05-21 Masakiyo Takahashi 糖尿病治療薬
US5962030A (en) * 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
WO1998051302A1 (en) * 1997-05-15 1998-11-19 University Of Washington Composition and methods for treating alzheimer's disease and other amyloidoses
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
AU4031500A (en) * 1999-03-26 2000-10-16 Akesis Pharmaceuticals, Inc. Edible solids for treatment of glucose metabolism disorders
CA2310513A1 (en) * 2000-05-31 2001-11-30 Vladimir Vuksan Compositions and methods for reducing blood glucose
US7326404B2 (en) * 2000-05-31 2008-02-05 Vuksan Holdings Inc. Konjac-mannan and ginseng compositions and methods and uses thereof
US20020098247A1 (en) * 2000-11-02 2002-07-25 Komorowski James R. Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
TWI329516B (en) * 2000-12-12 2010-09-01 Kaneka Corp Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity
EP2500018B1 (de) * 2002-03-08 2017-07-19 PhilERA New Zealand Limited Verhindern und/oder Behandeln der kardiovaskulären Erkrankung und/oder zugehöriges Herzversagen
US6787163B2 (en) * 2003-01-21 2004-09-07 Dennis H. Harris Therapeutic treatment for blood sugar regulation
US6884420B2 (en) * 2003-05-19 2005-04-26 Cross Bay, Llc Composition and method for reducing blood glucose
EP1874285B1 (de) * 2005-04-07 2009-10-07 Astrum Therapeutics Pty, Ltd. Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes

Also Published As

Publication number Publication date
CN101437503A (zh) 2009-05-20
WO2007098240A3 (en) 2008-04-10
EP1996176B1 (de) 2010-05-19
US20070254047A1 (en) 2007-11-01
AU2007217500A1 (en) 2007-08-30
WO2007098240B1 (en) 2008-06-05
WO2007098240A2 (en) 2007-08-30
DE602007006641D1 (de) 2010-07-01
US20090169648A1 (en) 2009-07-02
EP1996176A2 (de) 2008-12-03
CA2643299A1 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
DE602007006641D1 (de) Zusammensetzungen zur verringerung des blutglukosespiegels und zur behandlung von diabetes
EA200900733A1 (ru) ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНА, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ НАРУШЕНИЙ И БОЛЕЗНЕЙ, СВЯЗАННЫХ С АНГИОГЕНЕЗОМ
MA30914B1 (fr) Dihydropyrazolones substituees utilisees dans le traitement de maladies cardiovasculaires et hematologiques.
EA200870254A1 (ru) Способ лечения воспалительных заболеваний
WO2009137465A3 (en) Compositions for treatment or prevention of pathological cardiac remodeling and heart failure
AU2016335968A1 (en) Resetting biological pathways for defending against and repairing deterioration from human aging
WO2009091550A3 (en) Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis
WO2008021196A3 (en) Methods and compositions for the treatment of medical disorders
WO2007115282A3 (en) Use of ketogenic compounds for treatment of age-associated memory impairment
BRPI1015120A2 (pt) composto de lipídeo, composições farmacêutica e de lipídeo, métodos de produção de composto de lipídeo e para prevenir ou tratar doenças e usos de pelo menos um composto
EA200900940A1 (ru) Фармацевтическая композиция, содержащая пиразол-о-глюкозидное производное
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
EA201270666A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
EA201001865A1 (ru) Противовоспалительные агенты
MX2010005186A (es) Tiazolopiridinas solubilizadas.
WO2008054639A3 (en) Use of a catechin or polyphenol to treat ocular diseases and infection
BRPI0713447A2 (pt) composição forma de dosagem oral sólida, e, método para o tratamento de dor
UA106209C2 (en) Choline cocrystal of 5-[(1z,2e)-2-methyl-3-phenylpropenylidene]-4-oxo-2-thioxo-3-thiazolidine acetic acid
EA201200968A1 (ru) Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин
WO2007064932A3 (en) Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
SI2268292T1 (en) Method and compositions for the treatment of cancer
ECSP088348A (es) Composiciones de suplemento de hierro con tolerancia mejorada
MX2010003269A (es) Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa.
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
WO2007012057A3 (en) Vegetation water composition for treatment of inflammatory skin conditions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties